is...paranoid
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What? No. That's part of the problem! Lol It's not a scam but we get questions like "Why is $@*#! not registered in California? Something fishy here! Beware!" Well, the answer to that is that they are registered in Nevada. & they won a court case against J&J and they were mentioned in Forbes. I dont think Forbes would get their DD wrong before publishing that.
Yes I've read it. Arguably I don't understand how it relates to our problem though. It's not really all my posts that get removed constantly that bothers me. It's the ones from people who make intelligent comments or observations that get removed for being O/T, although what truly is ON topic could be debated no? My complaint, gripe.....crying over.... is on behalf of all those who get tired of re-hashing out old details, old posts from arguments months ago, and I guess feeling like I have to protect my investment from a basher who says they never plan on holding any positions. Obviously it's not against TOU to lie and say anything as long as it pertains to the company whose board you are posting on. It just gets old. I'm sure this kind of gripe started the 1st day ihub opened. Maybe I'll just get use to it and just continue to watch my words and remember to breath when it gets irritating.
I have the same problem. Actually says that he holds no position now, before, nor will he EVER hold a position in the company! But he sure like to take the 73 posts today and delete them down to 44 just because they dont agree with him. Please post what response you get and I'll try the same. Good luck
Is .04 really "moving" tho? Lol
I just mean that maybe we are out of the whole up to .12 down to .09 phase and maybe with this "good news everyone" and the decent financials we can maybe see upwards of .20 to .30 by the wk ending 12/20.....would be a great christmas present and birthday present for me as well! Not saying that I would take profits then of coarse though. I could be long, but I really need to read up more about them. Apparently there are people who really need this stock to rise again to recoup their loses. I will help them ;)
GLTA!
Really moved this past week! Cytosorb to Mother Russia eh comrade? Like Michaely Dee's, I'm lovin it! Good news following good news plus a great life saving product?! I'm proud of this one! Thanks for bringing it to my attention!
I read that too but then others on that board cried, "Troll!" & said it was bs and overpriced. I read that early this year Bayer put their BGM business up for sale for 5Bio but not even any bites so they took it off. Seemed the Medicare competitive bidding prices are not good for these GIANTS but perfectly fitting for some smaller players like.....oh I dont know, what's their name? Shasta? Genstrips? Yep! DECN
The future is where it's at. Genstrip has just begun selling. We're riding on sunbeams and rainbows and ya know what? You don't get a rainbow without a little rain! This 10Q does not bother me, nor anyone else who understands that the next 10Q is where we can begin to judge. That and any news that comes with it along the way. Shorts will be licking their chops at this thinking it will be good for them. Hope they remember what happened last time they shorted for a huge loss....
oh well
Im sure everybody has been in your predicament! If it helps, I took a decent loss in order to pick up more shares of decn around $.61....looks like I made a good choice! Good luck and drink some pepto in the morning!
3rd run up! "This decn" is moving up solidly! The ones trying to keep it down wont succeed!
Dont forget when Alydyr posted....
" That said, I have never held a position in DECN, nor do I intend to. That makes me an ubiased observer."
He's just a good samaritan trying to guide us away from an evil(?) company that is just trying to take all your monies thru this iHub as you call it.
GL to evverybody!!!!
Thanks Leirum, another good post everyone should read! & maybe we should estimate on the lesser side of the market share and say they only get .1% .....that's not a bad start! Cant wait to see the next financial statement...
Funding: The estimated cash cost of the pilot, including capital and certain operating expenditures and the cost of CO2 over two years, will total approximately $20 million, with most of these expenditures incurred by March 2014. The pilot will be funded by the Company's existing cash balances and the proceeds of the Company's convertible preferred equity issuance to One Stone Energy Partners completed in May 2013
Buying now is a good bet and was a good bet a month ago too. I'd hold this stock for months and years now that they are getting their product out there to compete in such a large market. LOL but hey thats just IMO
Yea, I traded this stock months ago and it wasnt rly a big mover. Some days there would only be a couple trades totaling a couple hundred shares. All the pr and everything on the site looks the same as it did then. Just wondered if maybe there was some kind of change happening.
-thanks
Something happening here. Huge gain in volume today outta nowhere
Perhaps it was the bailiff! He had very shifty eyes! Or maybe we are all psychic and read the judges mind back when 4 other USPTO judges ruled that DECN had a very good chance of winning :)
Are we all insiders? Because MOST of us have been saying we were gonna win as if it were common knowledge. So yes, we all knew in advance and thats why we bought shares :) Also, the price has went up .04 in the past 40 min I've been home!
This is where I stopped reading.....
Investors Hub Has Been Paid $5,000 (Five Thousand Dollars) By SMARTSTOCKS LLC To Disseminate This And Other Advertisements
Did it say they were paid by DECN anywhere there? Thats all you would have had to post. Who cares anyway? Anyone heeding your "warnings" or whatever they are are making a foolish decision by not looking at the chart. The chart matched with your claims dont add up. Don't regular P&D's rise then fall or "dump" back down to pre pump levels? That didn't happen. Get over it and find something new to say please!
Dividends or company growth? potato/tomato! Whats good for the goose is good for us ganderers! Thank you for your input! You have been around this board a long time respectively. I value your insight.
True & that other board is bat poop crazy! LOL
The thought that management might "give" it to the shareholders never crossed my mind. Would def be of better use building, expanding, advertising the Genstrip. Tonight we've been going in ridiculous circles. Which is exactly what wld happen once all the posts you're suggesting hit. I hate to see people being mislead by ppl who must be inteding to short this stock. What else could their angle be? Recently someone posted about the % short. With all the good news, the only way it could go down is if they get rumors going or dominate the message board with short 8 word posts suggesting that the company isn't real or some other nonsense. Then, instead of talking about all the good things happening, we get stuck rehashing out all the old topics that have been answered already so that any new investors don't get duped. At least thats how I feel. I'm Sammypt & I'm a real person that's not getting paid to write anything on here. GLTA
No the tuna in a can that you're suggesting is that the financial institution that made the deal with DECN to give them the credit line is a shareholder. Based on a broken link that someone else commented was from 2008. You said something about wondering if just because it'd been 5 years and different management that it didn't matter. What would it matter? If they were shareholders AND gave them a ridiculous credit line that wont split the shares up what would their end goal be thats so nefarious? Even if it were true, which btw we dont know , what are you suggesting is fishy about it?
Every couple weeks he liked to tout that Walmart flew him to Bentonville, AR to give "talk" mainly to vendors about how they would have to drive their costs lower and lower in order to keep selling at walmart and that almost ALL products at walmart net a profit of $0 for the manufacturers. So I'm making the assumption that he is really a walmart greeter posing as whatever he says he was. Even if he was? WHO CARES! That's a common assumption any chump could make. Yes its believable, but to say its bad for a company to sell its product at the largest retail chain in the world? Thats pushing sillyness...
AGREE I wonder what the walmart greeter has to say about it? Genstrips should be on the shelves there soon so it is pertinent to DECN. ;) I am wondering if they will wait till the 6th or 7th to post it tho. All of these "official court dates" seem to be more of guidelines than actual dates that the info is released. Idk. This is my first experience with a stock going thru litigation. & baby, it is going GOOD!!!!!
GLTA especially DECN
That's crazy! You've never said anything deserving of getting banned! I've come very close to posting something that would get me banned from there. About that MOD. I absolutely HATE that guy! My sister in law thinks its hilarious how worked up I get over an internet message board, but when he posts
PRICE COLLAPSE when there was literally a half a cent drop for the day?!?! 0.o That just pisses me off
Mr S said..."the beginning of a message board campaign to share the $12.7 million with NOBO shareholders. That is the only thing about the victory I have feared." See that last sentence? Yeah. These other guys getting worked up over nothing. I dont think Mr S is actually very sensitive to ppl who bash this stock or that post false or misleading statements. His comment referenced the fishy smell another member on here smells after every bit of news that comes out.....and that maybe that user might be too close to their armpit from which the smell is emanating ;)
BACK TO WORK! *WHIPISH*
Has anyone read DECN board today? Huge news before it hits the wires involving 1 of the court cases! Guess who it was in favor of? ;) Ooooooooh yeeeeeeaaaaaa! As Macho Man would say! A guy on the board reads the court releases everyday at 11am and found the one where DECN was ruled in favor for. I'm now following that guy ;) lol
Hadn't seen cdnboy posting on there lately so wanted to let him know fo sho...
I'd like to also take time to thank Struk for his spot on prediction of what happened to the decn stock price during the time of the paid spammers. I really got scared for a bit there. Was nice to have a good opinion of what could & DID actually happen...well, all except for the last part.....the 3rd RUN to the freakin MOON baby! Lol I most def hope that one happens! Altho I dont mind a slow n steady raise in share price either when the company is actually selling its product and not just relying on press releases of court cases to bump share price up.
Anyone who hasn't yet....better jump on DECN while it's still under a buck!
GLTA especially our lil diabetic testing strip company thats setting J&J ablaze, DECN :)
I'm looking for some kind of connection but found none so far. Keep us posted and plz supply link if you do! Thanks
Has this been posted? I know it's rehashing what most of us already know but I hadn't seen anyone link to accesswire yet.... I dont think at least! I like the way this is laid out. Good DD for anyone wondering about the credit line & especially those who might say, "DECN should have waited until it was [finalized] before they release a PR talking about what 'might' happen"
GLTA especially DECN fanboys like Fufat ;) http://www.accesswire.com/409017/Decision-Diagnostics-Receives-Signed-Term-Sheet-Agreement-For-125-Million-Revolving-Credit-Facility-Which-Will-Complete-DECNs-GenStrip-Roll-Out-Plan
Mr. Berman concluded, "we also note that in August and September 2013 we received several favorable court rulings and our competition ended their practice of sending threatening letters to our customers. Earlier this week we announced the receipt of a $12.5 million non-dilutive credit line, adding to the positive outlook for Genstrip sales by allowing us to grow to $250+ million in sales."
I like this part of the PR
From the Nevada Register
https://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=3NSRbjS9yzaGAd9NeLwuug%253d%253d&nt7=0
https://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=3NSRbjS9yzaGAd9NeLwuug%253d%253d&CorpName=DECISION+DIAGNOSTICS+CORP.
thank you Leirum...
glad we can rehash all this out again for any newbies confused by the bipolar-ism plaguing this DECN ;)
My bad. You answered yourself on 9/3/13
per you....
"Commission File Number: 000-29315
DECISION DIAGNOSTICS CORP.
(Exact name of registrant as specified in its charter)
Nevada
91-2105842
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
2660 Townsgate Road, Suite 300, Westlake Village California
91361
(Address of Principal Executive Offices)
(Zip Code)
(805) 446-1973
(Registrant’s telephone number, including area code)
Decision Diagnostics Corp.
(Former name, former address and former fiscal year, if changed since last report)"
....when Alydyr was asking about where to find DECN is registered in California.....
Thanks for your opinion!
Somewhere a Walmart store is missing a door greeter... One who tells all the vendors as they pass through that all the products they are selling will never return a profit to them. Best case scenario is that they break even. The vendors greet him with a nod of the head and a smile, "Thank you for your insight and wisdom," they say. Even the cashiers at Walmart have their opinions! Yes the profits may be small but with great sales volume comes great sales revenues. Yes, it is still too early to say that Genstrip's will definitely be a major seller but we can speculate based on the facts that this company is NOT just a shell company or a "start-up" or in "major focus changing to snake oil hubba baloo", but one who is opening a line of credit in order to distribute and market their product without the dilution of their shareholders investment or trust.
J&J put up 12.5 mio bond & this credit line being the same.... I noticed too! My 1st thought was that J&J had been ordered to pay up! Would have been some SUPER NEWS that would show up on J7J's news tab as well, but alas that will come with time. Maybe Nov 6th? I haven't went back and checked the court dates recently. Exciting news none the less and we didn't close red even tho in the long run I'm not too worried about what happens in a single day because this company will still be here tomorrow and the next! .....unless they get gobbled up by J&J who even tho I hate that "evil empire" as someone called it..... I would gladly exchange my shares of DECN for theirs! LOL I know it doesn't work that way btw ;) Anyways, GLTA
I would tell you that neither of those matter. After selling its handset division to microsoft, Nokia will have calved off a falling iceberg (to put it figuratively). Nokia will be making their money from patents, software, and network components. There is good speculation M&A will pick up alcatel and once merged they will take on Erricson who has been dominating that field. I think it would be accurate to look at erricson's share price and assume Nokia will be close to that within 2 -5 yrs. IMO and considering they do business as usual without that enormously heavy but very nice hand set holding them down ;) Do some more DD obviously as mine may be a little vague and forward looking. I did mine 4 months ago and this was the first stock I bought upon re entering the market.
Awe C'MON! YES, this company has lots of opportunities to "capitalize" on! Yuk yuk yuk ;) New article on Seeking Alpha is awesome too! If anything...I EXCLAIM quite often!!!!! But so does Giovanni! Caio!
GLTA!!!!
Great price to buy! .60s have shown in the chart to hold well. Once investors start noticing this company for legitimate reasons and not just because of spamming done by a group that WAS NOT paid for by DECN, we will see a share price increase to the .70s or .80s for a couple days, and then a run up to over $1 tp maybe $2 IMHO
Because even with all that spamming, the price only dropped into the .50s a few times before shares were gobbled up by those who saw a good deal on the table.
Looking GOOD here at DECN since the attempt by a rouge group of daytraders tried UNSUCCESSFULLY to demolish share price & ruin investor confidence. As Nov 6th get closer and more media outlets start covering how a small penny stock company is about to win a settlement against the 14th largest market capital in the world JnJ, investors will flock.
This is why I invest my time/money with this company. Thank you Leirum for your posts and insight!
inShare0Icon_alert_keyOn October 1, 2013 Decision Diagnostics Corporation (OTCBB: DECN) announced in a press release that they have scheduled bulk shipments of their first proprietary product, the Shasta GenStrip™ glucose test strip that is compatible with Johnson & Johnson’s Lifescan Ultra glucose monitoring devices.
Decision Diagnostics has primarily been a prescription and non-prescription diagnostics and home testing products distributor up until now. The company primarily sold distributed brand name lines of diabetic, wound care and post surgical medical products. Now with the launch of their first proprietary product, Decision Diagnostics is positioned to significantly grow their revenues and earnings over the next few years.
Decision Diagnostics’ revenues from its distribution business peaked in 2010 with $18.9 million and has fallen each year since, booking $12.1 million in 2011 and $6.1 million in 2012. The distribution business continually suffered from squeezed margins by competitive pricing and it became increasing difficult for Decision Diagnostics to be profitable in the distribution business. Management decided over the last few years to cut unprofitable and low margin lines from their business reducing the overall revenues of the company, while not impacting the bottom line substantially. For the management team the distribution business was a means to an end. Decision’s management used the distribution business to offset the development costs of their proprietary products. Management focused product development along two fronts, home diagnostic products and information technology (IT).
Decision Diagnostics’ IT product is centered around smart phone technology to provide physicians with up to date point of care, patient information. The company is prosecuting a patent covering 104 processes and methods. Decision Diagnostics completed development of this product set, and it intends to proactively protect its intellectual property in this market. The Remote Medical IT market was expected to be able to reduce overall health cost and improve patient care, but the rollout has been delayed due to lack of guidance in regards to this technology in the Affordable Care Act. This technology is now just beginning to emerge in as a cost saving tool for private insurers
The Shasta Genstrip is Decision Diagnostics’ first proprietary product to go to market. The Genstrip is a blood glucose monitoring test strip for in-home use, which can be used with existing Lifescan Ultra meters from Johnson & Johnson. Decision Diagnostics management has stated that they expect the price of the GenStrip products to be nearly half of the name brand competitors with similar performance. In April 2013, Decision Diagnostics announced a second version of GenStrip primarily for the Medicare market. This product will help serve the Medicare market that changed substantially when Medicare implemented rules from the Affordable Care Act, effectively lowering payment rates for diabetic related products by almost 70%, which in turn shifted the mature mail order pharmacy niche toward traditional walk-in pharmacies who can now compete for the Medicare business. This Medicare change has thrown many distributors into turmoil as this payment change cuts into distributors’ margins. The unintended consequences of these Medicare cuts have decimated many in the mail order pharmacies who no longer have a viable business model. Decision Diagnostics management believes the dual market focus of the easy to produce and lesser expensive GenStrip will alleviate much of the margin pressure on distributors and increase demand for the product line.
Decision Diagnostics filed the SE 510-K application in December of 2010. The U.S. FDA approved the 510-K for Genstrip and finally cleared Genstrip for marketing in the U. S. on November 30, 2012. Decision Diagnostics had nearly 2 years of market study and planning for the product while awaiting clearance. In an interview from November 28, 2012, the company’s CEO, Keith Berman said, “We used this time to familiarize the market with the upcoming product through the company’s normal and historical distribution channels. We secured a supplier contract with Wal-Mart Stores in an incredible 35 days.” During this time it became clear to the company that initial interest in Genstrip was greater than the manufacturing capacity and management decided to stop taking early pre-orders for the product until the manufacturing capacity issue was resolved. The rollout has been further complicated by several legal actions brought by Johnson & Johnson.
There currently are several lawsuits and counter suits going on between Johnson & Johnson and Decision Diagnostics regarding Genstrip. Decision Diagnostics’ FORM 10-Q dated June 30, 2013 has the following summary of the legal issues:
The closing of the processes with the FDA, Genstrip’s FDA clearance, and its initial sales drew the attention of the platform manufacturer, the Johnson and Johnson, Inc. (“J&J”). In September 2011, J&J through its Lifescan Scotland Ltd. Subsidiary and later its Lifescan, Inc. subsidiary, brought suit against the company and others for patent infringement causes of action related to the clearance and launch of Genstrip. In December 2012, ten days after the company received notice of the FDA clearance, J&J and its Lifescan, Inc. subsidiary brought suit against the company and others for issues of trademark infringement and trade dress. Both of these suits, have complicated the company’s ability to launch Genstrip into the large and growing diabetic market, and to brand the product. At various times the company has been temporarily enjoined from selling the Genstrip product, or manufacturing the Genstrip product.
At various times J&J through its Lifescan subsidiary have contacted the company’s customers using information gained from the litigation (and thought to be under seal) and the customers of our customers through the mails using long threatening letters to impede Genstrip sales. All Genstrip distribution activities have been affected at various times.
In May 2013 the United States Circuit Court restored the company’s ability to sell Genstrip. In July 2013 the U.S. District Court agreed to hear a contempt charge against J&J’s Lifescan subsidiary for the threatening letter writing activities using (supposed) customer lists though to be under seal.
In April 2013, as a part of its defense in the September 2011 suit, the company filed with the USPTO the Institution of Inter Partes Review under 37 C.F.R. § 42.108, requesting that the USPTO review the claims in J&J’s Patent 7,250,105, the Patent that is J&J’s foundation in the September 2011 suit. On August 15, 2013 the company received notice from the U.S. Patent and Trademark Office (“USPTO”) that a four judge panel determined, in Case IPR2013-00247, (J&J) Patent 7,250,105, that “…(the company’s subsidiary) Pharmatech has demonstrated that there is a reasonable likelihood of its proving unpatentability of claims 1-3 of the [7,250,]105 patent by a preponderance of the evidence.” The J&J Patent 7,250,105 is the primary patent being litigated in the September 2011 suit..
With the legal issues now moving ahead it may take a few years before everything is resolved. However, recent court rulings have gone in the direction of Decision Diagnostics. Forbes put out an article on September 11, 2013 titled “J&J Seeks Court Aid To Protect Its Glucose Monitoring Test” that discusses these legal issues. The conclusion of the article is interesting in that the author of the article suggests, “An easy solution on this issue would be for J&J to resort to its active M&A strategy. With Decision’s low market capitalization, it wouldn’t be improbable to expect that J&J may just opt to gobble up Decision Diagnostics to add to its growing list of acquisitions.” Should something of this nature occur, Johnson and Johnson would alleviate the legal costs and have a new cost effective product line for the Medicare sector in Genstrip
There are still risks ahead for Decision Diagnostics. The most obvious risk is the company could loose their legal challenges with J&J, and be enjoined for selling GenStrip, although recent rulings in Decision’s favor gives the appearance that this prospect is abating. Also, Decision Diagnostics is a small company without much cash on the balance sheet. The company has been in negotiations for a commercial line of credit for the funding of Genstrip sales and for the increased manufacturing of GenStrip, but no final announcement with financing details has been released. Management mentioned this line of credit in an October 3rd press release indicating that the closing may be imminent. The credit line will allow Decision Diagnostics to address their weak balance sheet and to fulfill existing and future orders. Another risk is being a small company, Decision Diagnostics will have to have the ability to grow the company if demand for their products is as strong as management believes, but this ultimately is a good problem to have.
GenStrip could change the landscape of the glucose monitoring market, especially in the Medicare market, with its favorable price points. Decision Diagnostics has been long waiting to ship orders for large box quantities of GenStrip to their distributors, and now it looks like their patience is being rewarded. The global market for diabetic diagnostic products was estimated to be $11.3 billion in 2010 and experts believe the market will grow to $32 billion by 2017. Just a 1% sliver of this market in 2017 will be worth $320 million in revenues to a company with products capable of market penetration. Decision Diagnostics’ management feels that even with small market penetration of their lower priced Genstrip, they will positively impact many diabetics’ lives that struggle financially. With legal issues moving forward, manufacturing expanded, and Medicare pay issues providing further product demand, Decision Diagnostics, after a long process, has reached the point shipping product and reaping their rewards.